Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats

Biochemical Pharmacology

Volumn 58, Issue 3, 1999, Pages 517-524

  Kawamura, Minoru ^a,c   Eisenhofer, Graeme ^a   Kopin, Irwin J ^a   Kador, Peter F ^b   Lee, Yong S ^b   Tsai, Jen Yue ^b   Fujisawa, Shigeki ^b   Lizak, Martin J ^b   Sinz, Andrea ^b   Sato, Sanai ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c Nippon Zoki Pharmaceutical Co   (Japan)

Author keywords

3,4 dihydroxymandelaldehyde; 3,4 dihydroxyphenylglycol; Aldehyde reductase; Aldose reductase; Norepinephrine; Sympathetic nervous system

Indexed keywords

3,4 DIHYDROXYMANDELALDEHYDE; 3,4 DIHYDROXYMANDELIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; AMINE OXIDASE (FLAVIN CONTAINING); IMIRESTAT; NORADRENALIN; PONALRESTAT; TOLRESTAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DEAMINATION; DRUG SELECTIVITY; ENZYME LOCALIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LENS; LIVER; MALE; MASS SPECTROMETRY; NONHUMAN; NORTHERN BLOTTING; ORAL DRUG ADMINISTRATION; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL; WESTERN BLOTTING;

ALDEHYDE REDUCTASE; ANIMALS; DEAMINATION; ENZYME INHIBITORS; FLUORENES; HYDANTOINS; MALE; METHOXYHYDROXYPHENYLGLYCOL; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SORBITOL; SUPERIOR CERVICAL GANGLION;

EID: 0032973893     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00121-5     Document Type: Article

References (31)

1. Graefe K-H and Henseling M, Neuronal and extraneuronal uptake and metabolism of catecholamines. Gen Pharmacol 14: 27-33, 1983.
2. Rutledge CO and Jonason J, Metabolic pathways of dopamine and norepinephrine in rabbit brain in vitro. J Pharmacol Exp Ther 157: 493-502, 1967.
3. Kopin IJ, Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 37: 333-364, 1985.
4. Turner AJ and Tipton KF, The characterization of two reduced nicotinamide-adenine dinucleotide phosphate-linked aldehyde reductases from pig brain. Biochem J 130: 765-772, 1972.
5. Tabakoff B, Anderson R and Alivisatos SGA, Enzymatic reduction of "biogenic" aldehydes in brain. Mol Pharmacol 9: 428-437, 1972.
6. Wermuth B and Münch JDB, Reduction of biogenic aldehydes by aldehyde reductase and alcohol dehydrogenase from human liver. Biochem Pharmacol 28: 1431-1433, 1979.
7. Wermuth B, Aldo-keto reductases. Prog Clin Kol Res 174: 209-230, 1985.
8. Huffman PL, Wermuth B and Wartburg JP, Human brain aldehyde reductases: Relationship to succinic semialdehyde reductase and aldose reductase. J Neurochem 35: 354-366, 1980.
9. Wermuth B, Burgisser H, Bohren K and von Wartburg J-P, Purification and characterization of human-brain aldose reductase. Eur J Biochem 127: 279-284, 1982.
10. Whittle SR and Turner AJ, Differential sensitivity of aldehyde reductase isoenzymes to sodium valproate. Biochim Biophys Acta 657: 94-105, 1981.
11. Jez JM, Bennett MJ, Schlegel BP, Lewis M and Penning TM, Comparative anatomy of the aldo-keto reductase superfamily. Biochem J 326: 625-636, 1997.
12. Sato S, Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney. Am J Physiol 236: F799-F805, 1992.
13. Old SE, Sato S, Kador PF and Carper DA, In vitro expression of rat lens aldose reductase in Escherichia coli. Proc Natl Acad Sci USA 87: 4942-4945, 1990.
14. Laemmli UK, Cleavage of structural proteins during assembly of the head of bacteriophage T4- Nature 15: 680-685, 1970.
15. Shiono T, Sato S, Reddy VN, Kador PF and Kinoshita JH, Rapid purification and properties of rat lens aldose reductase. Prog Clin Biol Res 232: 317-324, 1987.
16. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Plainview, NY, 1989.
17. Church GM and Gilbert W, Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995, 1984.
18. Kobayashi A and Fujisawa S, Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart. J Mol Cell Cardiol 26: 499-508, 1994.
19. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL and Kopin IJ, Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase. Clin Chem 32: 2030-2033, 1986.
20. Berkowitz B A, Moriyama T, Fales HM, Byrd RA and Balaban RS, In vivo metabolism of 3-deoxy-3-fluoro-D-glucose. J Biol Chem 270: 12417-12423, 1990.
21. 19F-NMR quantitation of lens aldose reductase activity using 3-deoxy-3-fluoro-D-glucose. J Biol Chem 266: 20970-20975, 1991.
22. Kawamura M, Kopin IJ, Kador PK, Sato S, Tjurmina O and Eisenhofer G, Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine. J Auton Nerv Syst 66: 145-148, 1997.
23. Sato S and Kador PF, Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem Pharmacol 40: 1033-1042, 1990.
24. Burke WJ, Schmitt CA, Gillespie KN and Li SW, Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells. Brain Res 722: 232-235, 1996.
25. Bhatnagar A, Liu SQ, Das B, Ansari NH and Srivastava SK, Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors. Biochem Pharmacol 39: 1115-1124, 1990.
26. Kador PF, The role of aldose reductase in the development of diabetic complications. Med Res Rev 8: 325-352, 1988.
27. Garcia-Perez A and Burg MB, Renal medullary organic osmolytes. Physiol Rev 71: 1081-1115, 1991.
28. Burg MB, Kwon ED and Kultz D, Regulation of gene expression by hypertonicity. Annu Rev Physiol 59: 437-455, 1997.
29. Warren JC, Murdock GL, Ma Y, Goodman SR and Zimmer WE, Molecular cloning of testicular 20α-hydroxysteroid dehydrogenase: Identity with aldose reductase. Biochemistry 32: 1401-1406, 1993.
30. Iwata N, Hara S, Nishimura C, Takahashi M, Mukai T, Takayama M and Endo T, Hormonal regulation of aldose reductase in rat ovary during the estrous cycle. Eur J Boochem 235: 444-448, 1996.
31. Petrash JM, Harter TM and Murdock GL, A potential role for aldose reductase in steroid metabolism. Adv Exp Med Biol 414: 465-473, 1997.